Jason O'Byrne

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason O'Byrne:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vir Biotechnology, Inc. EVP & Chief Financial Officer Common Stock 110,701 $615,165 $5.56 17 Nov 2025 Direct
Caribou Biosciences, Inc. Chief Financial Officer Option to purchase Common Stock 153,000 $352,390 $2.69 20 Feb 2024 Direct
Caribou Biosciences, Inc. Chief Financial Officer Common Stock 59,224 $159,313 $2.69 20 Feb 2024 Direct
Vir Biotechnology, Inc. EVP & Chief Financial Officer Stock Option (Right to Buy) 80,000 $122,400 $1.53 22 Feb 2025 Direct

Insider Reports Filed by Jason O'Byrne

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VIR Vir Biotechnology, Inc. 17 Nov 2025 1 -$37,782 4 EVP & Chief Financial Officer 18 Nov 2025, 14:47
VIR Vir Biotechnology, Inc. 22 Feb 2025 2 $0 4 EVP & Chief Financial Officer 25 Feb 2025, 15:41
VIR Vir Biotechnology, Inc. 15 Nov 2024 2 $0 4 EVP & Chief Financial Officer 18 Nov 2024, 13:36
VIR Vir Biotechnology, Inc. 02 Oct 2024 0 $0 3 EVP & Chief Financial Officer 03 Oct 2024, 17:11
CRBU Caribou Biosciences, Inc. 20 Feb 2024 2 $0 4 Chief Financial Officer 22 Feb 2024, 17:28
CRBU Caribou Biosciences, Inc. 21 Feb 2023 1 $0 4 Chief Financial Officer 23 Feb 2023, 15:47
CRBU Caribou Biosciences, Inc. 08 Feb 2022 2 +$100,021 4 Chief Financial Officer 08 Feb 2022, 18:27
CRBU Caribou Biosciences, Inc. 20 Dec 2021 1 $0 4 Chief Financial Officer 21 Dec 2021, 16:35
CRBU Caribou Biosciences, Inc. 22 Jul 2021 0 $0 3 Chief Financial Officer Exhibit 24 - Power of Attorney. 22 Jul 2021, 20:58